Keyphrases
Adenocarcinoma
50%
Adenocarcinoma Cells
25%
Cause-specific
25%
Clinical Patients
25%
Competing Events
25%
Confidence Interval
100%
Cox Regression
25%
Electronic Model
25%
Failure Pattern
25%
Failure Probability
25%
First Failure
100%
Fludeoxyglucose
25%
Fluorodeoxyglucose Positron Emission Tomography/computed Tomography
25%
Hazard Ratio
75%
Lesion Level
25%
Level Characteristic Values
25%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
100%
Lymph Node
25%
Multivariable Logistic Regression
50%
Non-small Cell Lung Cancer (NSCLC)
50%
Patient Data
25%
Patient-level
25%
Positron Emission Tomography
25%
Primary Tumor
50%
Prognostic Model
25%
Radiotherapy Planning
25%
Regional Failure
50%
Risk Model
100%
Single Institution
25%
Squamous Cell Carcinoma (SqCC)
50%
Standardized Uptake Value
50%
Medicine and Dentistry
Adenocarcinoma
100%
Chemoradiation Therapy
100%
Chemoradiotherapy
66%
Hazard Ratio
100%
Logistic Regression Analysis
66%
Lymph Node
33%
Non Small Cell Lung Cancer
100%
Non-Small Cell Lung Cancer
100%
Patient-Data
33%
positron emission tomographic scan
33%
Positron Emission Tomography-Computed Tomography
33%
Primary Tumor
66%
Proportional Hazards Model
33%
Radiation Therapy Planning
33%
Squamous Cell Carcinoma
66%
Standardized Uptake Value
66%
Nursing and Health Professions
Adenocarcinoma
75%
Chemoradiotherapy
100%
Confidence Interval
100%
Hazard Ratio
75%
Logistic Regression Analysis
50%
Non Small Cell Lung Cancer
100%
Patient Coding
25%
positron emission tomographic scan
25%
Positron Emission Tomography-Computed Tomography
25%
Primary Tumor
50%
Proportional Hazards Model
25%
Radiotherapy
25%
Squamous Cell Carcinoma
50%
Pharmacology, Toxicology and Pharmaceutical Science
Adenocarcinoma
100%
Chemoradiation Therapy
100%
Non Small Cell Lung Cancer
100%
Primary Tumor
66%
Squamous Cell Carcinoma
66%